SEC Form 4 · accession 0001179110-16-020229
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Lambert
Officer — Executive Vice President
Period of report
Feb 26, 2016
Accepted (ET)
Feb 26, 2016 · 3:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2016 | M | 3,889 | $3.19 | A | 110,746 | D | |
| Common Stock | Feb 26, 2016 | M | 7,000 | $5.77 | A | 117,746 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.19 | Feb 26, 2016 | M | 3,889 | D | Jun 8, 2007 | Jun 8, 2016 | Common Stock | 3,889 | 0 | D |
| Stock Option (right to buy)F2 | $5.77 | Feb 26, 2016 | M | 7,000 | D | Jun 12, 2008 | Jun 12, 2017 | Common Stock | 7,000 | 53,000 | D |
Explanation of responses
- F1Exercisable as to 11,667 shares commencing on June 8, 2007, 11,667 shares commencing on June 8, 2008, and 11,666 shares commencing on June 8, 2009.
- F2Exercisable as to 20,000 shares commencing on June 12, 2008, 20,000 shares commencing on June 12, 2009, and 20,000 shares commencing on June 12, 2010.